SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242,440 | +5.9% | 2,000 | 0.0% | 0.03% | +7.4% |
| Q2 2023 | $229,040 | -16.9% | 2,000 | 0.0% | 0.03% | -20.6% |
| Q1 2023 | $275,660 | +6.4% | 2,000 | 0.0% | 0.03% | +3.0% |
| Q4 2022 | $259,160 | +17.3% | 2,000 | 0.0% | 0.03% | +10.0% |
| Q3 2022 | $221,000 | -35.2% | 2,000 | 0.0% | 0.03% | -48.3% |
| Q4 2020 | $341,000 | +21.4% | 2,000 | 0.0% | 0.06% | +5.5% |
| Q3 2020 | $281,000 | -12.5% | 2,000 | 0.0% | 0.06% | -20.3% |
| Q2 2020 | $321,000 | +24.4% | 2,000 | 0.0% | 0.07% | +27.8% |
| Q4 2019 | $258,000 | -15.1% | 2,000 | 0.0% | 0.05% | -27.0% |
| Q2 2019 | $304,000 | +27.7% | 2,000 | 0.0% | 0.07% | +21.3% |
| Q1 2019 | $238,000 | +0.4% | 2,000 | 0.0% | 0.06% | -9.0% |
| Q4 2018 | $237,000 | -59.6% | 2,000 | -50.0% | 0.07% | -16.2% |
| Q3 2018 | $587,000 | +122.3% | 4,000 | +100.0% | 0.08% | +8.1% |
| Q2 2018 | $264,000 | – | 2,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |